Population pharmacokinetics of inhaled tobramycin powder in cystic fibrosis patients.

Ting, L; Aksenov, S; Bhansali, S G; Ramakrishna, R; Tang, P; Geller, D E

Ting, L; Aksenov, S; Bhansali, S G; Ramakrishna, R; Tang, P; Geller, D E.

Afiliación

Ting L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Aksenov S; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Bhansali SG; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Ramakrishna R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Tang P; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Geller DE; Florida State University College of Medicine, Orlando, Florida, USA.

CPT Pharmacometrics Syst Pharmacol ; 3: e99, 2014 Feb 12.

Article en En | MEDLINE | ID: mdl-24522146

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google